Stroke and Lipoprotein(a) - clinical studies.
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality
Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J.
Under a wide range of circumstances, there are continuous, independent, and modest associations of Lp(a) concentration with risk of CHD and stroke that appear exclusive to vascular outcomes.
Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis.
Atherosclerosis. 2015 Oct;242(2):496-503. doi: 10.1016/j.atherosclerosis.2015.08.021. Epub 2015 Aug 15.
Nave AH1, Lange KS2, Leonards CO2, Siegerink B2, Doehner W3, Landmesser U4, Steinhagen-Thiessen E5, Endres M6, Ebinger M7.
Elevated Lp(a) is an independent risk factor for ischemic stroke and may be especially relevant for young stroke patients. Sex-specific risk differences remain conflicting. Further studies in these subgroups may be warranted.